Peripheral Neuropathy Trial, Recruiting NCT07403331 Sponsor: Oslo University Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07403331
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had nerve pain in one or both legs for more than 6 months, caused either by a condition related to previous spinal surgery (Post Spinal Pain Syndrome, type 1 or 2) or by localised nerve damage.
  • People whose leg nerve pain is the main and most significant pain they experience.
  • People aged between 18 and 60 years.
  • People who have already tried standard non-surgical or surgical treatments for their pain without sufficient relief.
  • People whose current opioid (strong painkiller) use is below a specified daily limit at the time of the implant procedure (confirm with trial site).
  • People who are willing to actively take part in the full treatment programme offered by the trial.
  • People who live within a reasonable travel distance from Oslo, Norway.
  • People who can understand and communicate fluently in Norwegian, both spoken and written.
  • People who have the mental capacity to give informed consent to participate.
  • People who are able to learn how to operate the device's remote control to switch between programmes.

Who may not be able to join:

  • People who are currently going through a formal claims process for health or disability benefits, such as through NAV (the Norwegian Labour and Welfare Administration).
  • People who have a psychological or psychiatric condition that may affect how well the treatment works.
  • People who have widespread, generalised chronic pain throughout the body rather than pain confined to a specific area.
  • People who have other pain conditions in the same area, such as osteoarthritis.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lars-Petter Granan, Ph.D, Department of pain management and research, Oslo university hospital

Phone: +4723026161

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 May 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Pain intensity in leg(s); Physical function (PROMIS-29)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov